Company intelligence / Profile preview

Renalis

Cleveland, Ohio, United Statesrenalis.health ↗

Ownership: Private
Development stage: Other

Overview

CeCe®, the company's first product, has received FDA clearance as a prescription digital therapeutic for overactive bladder. Proof-of-concept results have been reported for OAB. The company focuses on delivering evidence-based behavioral therapy via mobile devices to improve accessibility and outcomes in pelvic health.

Therapeutic areas: UrologyWomen's Health
Modalities: Non-pharmacological therapyDevice (Prescription Digital Therapeutic)
Industry: Digital Health Medical Devices

Partnerships

Nurse Navigator Solutions LLC

Beyond the preview

Go deeper on Renalis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renalis.

Explore the full profile